Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
15.26
+0.89 (6.19%)
Feb 26, 2026, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 123 employees as of December 31, 2024. The number of employees decreased by 261 or -67.97% compared to the previous year.
Employees
123
Change (1Y)
-261
Growth (1Y)
-67.97%
Revenue / Employee
n/a
Profits / Employee
-$1,213,675
Market Cap
1.68B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 123 | -261 | -67.97% |
| Dec 31, 2023 | 384 | 122 | 46.56% |
| Sep 30, 2023 | 374 | 137 | 57.81% |
| Jun 30, 2023 | 338 | 112 | 49.56% |
| Mar 31, 2023 | 296 | 91 | 44.39% |
| Dec 31, 2022 | 262 | 57 | 27.80% |
| Sep 30, 2022 | 237 | 127 | 115.45% |
| Jun 30, 2022 | 226 | 116 | 105.45% |
| Dec 31, 2021 | 205 | 171 | 502.94% |
| Sep 30, 2021 | 110 | 76 | 223.53% |
| Dec 31, 2020 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,379 |
| Evotec SE | 4,788 |
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 2,028 |
| Alvotech | 1,012 |
| ANI Pharmaceuticals | 897 |
| BioCryst Pharmaceuticals | 580 |
AMLX News
- 21 hours ago - Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences - Business Wire
- 2 days ago - Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 - Business Wire
- 4 weeks ago - HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 7 weeks ago - Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S - Business Wire
- 2 months ago - Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial - Business Wire
- 3 months ago - Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 months ago - Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX - Business Wire
- 4 months ago - Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2025 Earnings Call Transcript - Seeking Alpha